Detalhe da pesquisa
1.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood
; 136(10): 1134-1143, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688395
2.
The costs of treating and not treating patients with chronic myeloid leukemia with tyrosine kinase inhibitors among Medicare patients in the United States.
Cancer
; 127(1): 93-102, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119175
3.
Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.
Cancer
; 126(1): 121-130, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31524955
4.
Real-world testing and treatment patterns in chronic lymphocytic leukemia: A SEER patterns of care analysis.
Cancer
; 125(1): 135-143, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30343488
5.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
6.
Modern, real-world patterns of care and clinical outcomes among patients with newly diagnosed diffuse large B-cell lymphoma with or without double/triple-hit status in the United States.
Haematologica
; 108(4): 1190-1195, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36453108
7.
Polatuzumab vedotin plus rituximab and lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study.
Lancet Haematol
; 11(2): e136-e146, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38190832
8.
The COVID-19 Pandemic and In-Person Visit Rate Disruptions Among Patients With Hematologic Neoplasms in the US in 2020 to 2021.
JAMA Netw Open
; 6(6): e2316642, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37273206
9.
How to Effectively Decrease Patient Co-Payments of High-Cost Drugs Through Innovation: Lessons From the Karmanos Specialty Pharmacy.
JCO Oncol Pract
; 18(1): e137-e151, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34406816
10.
The DISCO App: A pilot test of a multi-level intervention to reduce the financial burden of cancer through improved cost communication.
PEC Innov
; 1: 100002, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364004
11.
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study.
Clin Cancer Res
; 27(12): 3307-3316, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33785483
12.
Incorporating Value-Based Care Into Oncology.
Cancer J
; 26(4): 311-322, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32732674
13.
Challenges in the Clinical Application of the American Society of Clinical Oncology Value Framework: A Medicare Cost-Benefit Analysis in Chronic Lymphocytic Leukemia.
J Oncol Pract
; 13(12): e1002-e1011, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29144866
14.
Racial disparities in time to hematopoietic cell transplant among patients with hematologic malignancies at a large urban academic center.
Bone Marrow Transplant
; 57(7): 1213-1215, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35581406
15.
A Quantitative Analysis of Subclonal and Clonal Gene Mutations before and after Therapy in Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 22(17): 4525-35, 2016 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060156
16.
Colony-Stimulating Factor-1 Receptor Is Required for Nurse-like Cell Survival in Chronic Lymphocytic Leukemia.
Clin Cancer Res
; 22(24): 6118-6128, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27334834
17.
Rapid transitions in the standard of care for chronic lymphocytic leukemia (CLL).
Oncotarget
; 10(26): 2484-2485, 2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31069011
18.
Multidimensional single-cell analysis of BCR signaling reveals proximal activation defect as a hallmark of chronic lymphocytic leukemia B cells.
PLoS One
; 9(1): e79987, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24489640
19.
Clonal evolution, genomic drivers, and effects of therapy in chronic lymphocytic leukemia.
Clin Cancer Res
; 19(11): 2893-904, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23620403